ADMA Biologics, Inc.ADMANASDAQ
Loading
Year-over-year SG&A expense growth
3Y CAGR
+1.9%/yr
vs -2.2%/yr prior
5Y CAGR
-7.8%/yr
Recent acceleration
Acceleration
+4.1pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value |
|---|---|
| 2025 | 23.55% |
| 2024 | 25.59% |
| 2023 | 12.51% |
| 2022 | 22.29% |
| 2021 | 22.39% |
| 2020 | 35.28% |
| 2019 | 15.14% |
| 2018 | 24.37% |
| 2017 | 112.99% |
| 2016 | 25.92% |